Topscience Biotech | Successful Conclusion of CPHI Korea 2025
2025-09-01
醫(yī)療健康
個人護理
食品營養(yǎng)
其他應(yīng)用
眾智生物
From August 26 to 28, 2025, the CPHI Korea 2025 was successfully held at the COEX Convention & Exhibition Center in Seoul, South Korea. As a vital platform for the pharmaceutical industry to connect with the global market, this year’s exhibition brought together pharmaceutical companies from around the world, showcasing cutting-edge innovations and collaborative efforts within the global healthcare sector. Topscience Biotech actively participated in the event, presenting a range of innovative products in the pharmaceutical field and over 20 global certifications, comprehensively demonstrating the company’s innovation capabilities and international presence in the API market.
During the exhibition, Topscience Biotech's booth attracted significant attention. Its self-developed pharmaceutical and medical grade sodium hyaluronate, PDRN/PN, and other products drew extensive interest from professional visitors, making it one of the highlights on site. Thanks to its integrated advantages in ultra-low endotoxin levels, precise molecular weight customization, patented fermentation and purification technologies, and end-to-end temperature-controlled logistics, Topscience Biotech provides downstream customers with high-quality pharmaceutical ingredient solutions.
Over the three-day event, Topscience Biotech engaged in efficient meetings with global partners, facilitating in-depth exchanges and reaching consensus on product quality improvement, technical collaboration, and market synergy. These interactions have injected fresh momentum into the company’s further expansion in the Korean market.
With the successful conclusion of CPHI Korea 2025, Topscience Biotech has once again demonstrated the strength and potential of Chinese API manufacturers on the global stage. Over the past two decades, the company’s continuous dedication and innovation in pharmaceutical ingredients have earned recognition and trust from partners worldwide. Looking ahead, we anticipate joining hands with more industry peers to collectively witness Topscience Biotech’s next decade.
We cordially invite global partners to continue following Topscience Biotech’s journey and join us at the upcoming CPHI Worldwide 2025 in Frankfurt at Booth H61 in Hall 11.0, where we will explore further collaboration opportunities and shape the future of the industry together.
??2023 山東眾山生物科技有限公司
魯ICP備18038912號-1